Sanofi: all 2,424 studies
Page 24 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- Opposing Step-by-step Insulin Reinforcement to Intensified StrategyCompletedNCT00174642Phase 3
- GILT Docetaxel - Non-Small Cell Lung CancerCompletedNCT00174629Phase 3
- CORE: Capecitabine, Oxaliplatin, Radiotherapy and ExcisionCompletedNCT00174616Phase 2
- EXIBIT: Oxaliplatin in Biliary Tract CancerCompletedNCT00174564Phase 2
- Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal CancerCompletedNCT00160030Phase 2
- Mucopolysaccharidosis I (MPS I) RegistryCompletedNCT00144794
- A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated PatientsCompletedNCT00144768Phase 4
- Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus SurgeryTerminatedNCT00140608Not applicable
- Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the KneeCompletedNCT00139295Phase 3
- Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating HormoneCompletedNCT00137891Phase 1
- Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)CompletedNCT00135941Phase 3
- Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal InsulinCompletedNCT00135096Phase 3
- Variable Bolus Regimen 1-2-3 for Type 2 Diabetes MellitusCompletedNCT00135083Phase 3
- Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal InsulinCompletedNCT00135057Phase 3
- The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary InterventionCompletedNCT00133731Phase 2
- KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract InfectionsTerminatedNCT00132951Phase 4
- PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic BronchitisCompletedNCT00132938Phase 4
- An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic RhinitisCompletedNCT00132925Phase 3
- A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle OsteoarthritisCompletedNCT00131768Phase 3
- A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the HipCompletedNCT00131326Phase 3
- A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder OsteoarthritisCompletedNCT00131300Phase 3
- Seprafilm in the Reduction of Incidence of Bowel Obstruction in General SurgeryCompletedNCT00130715Not applicable
- TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to OsteoarthritisCompletedNCT00130468Phase 4
- OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal WomenCompletedNCT00130403Phase 4
- CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal CancerTerminatedNCT00129870Phase 4
- SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I PatientsCompletedNCT00126009Phase 2
- Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602CompletedNCT00125879Phase 2/3
- Clofarabine in Adult Patients With Advanced Solid TumorsCompletedNCT00125840Phase 1
- Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid TumorsCompletedNCT00125827Phase 1
- Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00125385Phase 1
- STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)CompletedNCT00124332Phase 3
- Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial InfarctionCompletedNCT00123565Phase 2
- Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary HyperparathyroidismCompletedNCT00123461Phase 4
- Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant RejectionCompletedNCT00117689Phase 2
- Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent ClaudicationCompletedNCT00117650Phase 2
- Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and AdolescentsCompletedNCT00115570Phase 3
- Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)CompletedNCT00115375Phase 2
- Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic MalignanciesTerminatedNCT00113048Phase 1
- Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe DiseaseCompletedNCT00113035
- A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated DiarrheaCompletedNCT00106509Phase 3
- Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's TypeCompletedNCT00104013Phase 3
- 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's TypeCompletedNCT00103649Phase 3
- Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.TerminatedNCT00102128Phase 2
- Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal FunctionCompletedNCT00094965Phase 2
- Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck CancerCompletedNCT00094081Phase 3
- HP184 in Chronic Spinal Cord Injury SubjectsCompletedNCT00093275Phase 2
- A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant RejectionCompletedNCT00089947Phase 2
- Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell TransplantCompletedNCT00088543Not applicable
- Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine TreatmentCompletedNCT00087958Phase 2
- Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00087802Phase 3
- Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid TumorsCompletedNCT00086528Phase 1
- Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With DocetaxelCompletedNCT00082134Phase 2
- A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical CareTerminatedNCT00081900Phase 1/2
- Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast CancerCompletedNCT00081796Phase 3
- Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in AdultsCompletedNCT00079820Phase 1
- Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CarcinomaCompletedNCT00078455Phase 2
- An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone MassTerminatedNCT00078026Phase 1/2
- Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHLTerminatedNCT00077961Phase 1/2
- Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)CompletedNCT00077844Phase 2/3
- Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)CompletedNCT00077818Phase 4
- PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)CompletedNCT00077805Phase 4
- Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)CompletedNCT00077792Phase 3
- EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged ImmobilizationCompletedNCT00077753Phase 4
- A Prospective, Observational Study in Patients With Late-Onset Pompe DiseaseCompletedNCT00077662
- A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry DiseaseCompletedNCT00074971Phase 3
- Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe DiseaseCompletedNCT00074932Not applicable
- Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe DiseaseApproved for marketingNCT00074919
- SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein ThrombosisCompletedNCT00071279Phase 3
- ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)CompletedNCT00071188Phase 2
- Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)CompletedNCT00070655Phase 3
- A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following ProstatectomyCompletedNCT00069888Phase 2
- Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-ThalassemiaCompletedNCT00069862Phase 1/2
- Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic MelanomaCompletedNCT00068211Phase 2
- Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)CompletedNCT00067093Phase 3
- ZD6474 in Treating Patients With Small Cell Lung CancerCompletedNCT00066313Phase 2
- SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary EmbolismCompletedNCT00062803Phase 3
- This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.CompletedNCT00059722Phase 2
- A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe DiseaseCompletedNCT00059280Phase 2/3
- rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)CompletedNCT00053573Phase 1/2
- Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox VaccinationTerminatedNCT00053508Phase 2
- A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type IICompletedNCT00051935Phase 2
- Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's LymphomaTerminatedNCT00051701Phase 1/2
- Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)CompletedNCT00050817Phase 3
- Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney CancerCompletedNCT00050323Phase 1/2
- This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.CompletedNCT00047840Phase 2
- Efficacy Study of ZD6474 to Treat Multiple Myeloma CancerCompletedNCT00047788Phase 2
- A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors.CompletedNCT00046696Phase 1
- Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic LeukemiaCompletedNCT00046683Phase 3
- Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes AdolescentsCompletedNCT00046501Phase 3
- Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other TreatmentCompletedNCT00046462Phase 3
- 12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.CompletedNCT00046150Phase 3
- Long-Term Safety Performance of Fexofenadine in AsthmaCompletedNCT00045955Phase 3
- Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous LeukemiaCompletedNCT00044889Phase 2
- Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent AsthmaCompletedNCT00044824Phase 3
- Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent AsthmaCompletedNCT00044811Phase 3
- Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & ThiazolidinedioneCompletedNCT00044447Phase 3
- SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary SyndromesCompletedNCT00043784Phase 3
- Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic SclerosisCompletedNCT00043706Phase 1/2
- Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) PatientsCompletedNCT00042354Phase 2
- Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)CompletedNCT00042341Phase 2